Azo dyes and human health: A review

IUPAC, Compendium of Chemical Terminology, 2

Mock GH, In Kent and Riegel's, Handbook of Industrial Chemistry and Biotechnology, 11, 449

Meyer U, In Microbial Degradation of Xenobiotics and Recalcitrant Compounds. FEMS Symp, 1981, 371

Anon, German Ban of Use of Certain Azo Compounds in Some Consumer Goods. ETAD InformationNotice, 28, 11

Puvaneswari N, Indian J Exper Biol, 44, 618

Mossvi S, Dyes and Pigm, 7, 723

Hildenbrand SF, Int Arch Occup Enviro Health, 72, M052

Correia VM, Environ Technol., 15, 917, 10.1080/09593339409385500

Domagk G, Dtsch med Wochenschr, 61, 250, 10.1055/s-0028-1129486

Tréfouël JT, C R Soc Biol., 120, 23

Hörlein H, Deutsches Reich Patentschrift Nr, 226239

Colebrook Turk JL. Leonard, J Royal Soc Med, 87, 727

Ellis H, Brit J. Hosp Medici, 72, 109, 10.12968/hmed.2011.72.2.109

Miller JA, J Exp Med., 87, 139, 10.1084/jem.87.2.139

Chung KT, Mutat Res, 58, 375, 10.1016/0165-1218(78)90033-2

Chung KT, Appl Environ Microbiol, 42, 641, 10.1128/AEM.42.4.641-648.1981

Miller JA, Cancer Res, 17, 387

Chung KT, Mutat Res, 114, 269, 10.1016/0165-1110(83)90035-0

Chung KT, Mutat Res, 277, 201, 10.1016/0165-1110(92)90044-A

Chung KT, Crit Rev Microbiol, 18, 175, 10.3109/10408419209114557

Chung KT, Environ Toxicol Chem, 12, 2121

Platzek T, Hum Exper Toxicol, 19, 552

Stingley RL, J Med Microbiol, 59, 108, 10.1099/jmm.0.012617-0

Feng J, Front in Biosc Elite, 4, 568

Morokutti A, Biochem, 44, 13724, 10.1021/bi0510835

Ito K, J Biol Chem., 28, 20567

Liu ZJ, Arch Biochem Biophys, 463, 68

Chen H, Microbiol., 154, 2659, 10.1099/mic.0.2008/019877-0

Wang CJ, J Mol Biol, 373, 1213, 10.1016/j.jmb.2007.08.048

Liger D, J Biol Chem, 279, 34890, 10.1074/jbc.M405404200

Martins MAM, Chemosphere, 38, 2456

Douch PGC, Xenobi, 5, 773, 10.3109/00498257509060378

Douch PGC, Xenobi, 5, 279, 10.3109/00498257509052062

Weber EJ, Environ Sci Technol, 29, 1163, 10.1021/es00005a005

Keck EK, Appl Environ Microbiol., 63, 3684, 10.1128/AEM.63.9.3684-3690.1997

Nam S, Chemospher, 40, 351, 10.1016/S0045-6535(99)00226-X

Hong Y-G, Appl Microbiol Biotechnol, 88, 837

Aaron JJ, Tr J Chem, 25, 509

Guivarch E, Environ Chem Lett, 1, 38, 10.1007/s10311-002-0017-0

Tantak NP. Chaudhari S, J Hazard Materials B, 136, 698, 10.1016/j.jhazmat.2005.12.049

Konstantinou IK, Appl Catlysis B: Environmental, 49, 1, 10.1016/j.apcatb.2003.11.010

Delclos KB, Cancer Res., 44, 2540

IARC, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, 9, 1

Nelson AA, J Natl Canc Inst., 13, 1497

Levine WG, Drug Metab Rev., 23, 253

Opie EL, The J Exper Med., 80, 231, 10.1084/jem.80.3.231

Stiborová M, Cancer Res, 62, 5678

Refat NA, J Biochem Mol Toxicol, 22, 77, 10.1002/jbt.20220

Han D, Agri Food Chem, 53, 6424

He I, Anal Chim Acta, 594, 139, 10.1016/j.aca.2007.05.021

Calbiani F, 2004, 1058-127-135

Delclos KB, Carcinogenesis, 7, 277, 10.1093/carcin/7.2.277

Ashby J, Mutat Res, 116, 271, 10.1016/0165-1218(83)90064-2

International Agency for Research on Cancer, WHO monogr. Ser., 8, 199

Nestmann ER, Carcinogenesis, 2, 879, 10.1093/carcin/2.9.879

Brown MA, Crit Rev Environ Sci Technol, 23, 249, 10.1080/10643389309388453

Chung K-T, Front BioSci Elite, 2, 29

Chung K-T, Front in Biosci Elite, 7, 367, 10.2741/e737

IARC, 2010, 99, 1

Chung K-T, Mutat Res., 12, 58

NTP. Toxicology and carcinogenesis studies of3, 3′-dimethylbenzidine dihydrochloride (Cas No. 612-82-) in 344/N rats drinking water studies.Technical Report Series. No 390, Research Triangle Park, NC. National Toxicology Program, 231 pp.Toxicol.1991;1: 475–490.

US Environmental Protection Agency, 3, 3′-Dichlorobenzidine. US Environmental Protection Agency, Integrated Risk Information System

US Environmental Protection Agency, Health Effects Assessment Summary Tables. FY 1997 Update

Beyerbach A, Carcinogenesis, 27, 1600, 10.1093/carcin/bgi362

Hoffman D, Prevent Med, 26, 427, 10.1006/pmed.1997.0183

Chiang TA, Fd Chem Toxicol, 37, 125

Richfield-Frantz N, J Chromat., 3, 109

Sittig M, Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2

US Department of Health and Human Services, The Newest Report on Carcinogens. 1998 Summary

Frey A,,Meckelein B, J Immunol Methods, 233, 47, 10.1016/S0022-1759(99)00166-0

10.1093/toxsci/56.2.351

Holland VR, Tetrahedron, 30, 3299, 10.1016/S0040-4020(01)97504-0

Yang J, J Phy Chem C, 112, 13065, 10.1021/jp802604d

Deshpande SS.Enzyme Immunoassays: From Concept to Product Development. New York: Chapman & Hall; 1996;169.

Prival MJ, 1984, 136, 33

Dillon D, Mutagenesis, 9, 295, 10.1093/mutage/9.4.295

Bonser GM, Br J Cancer, 17, 235, 10.1038/bjc.1963.33

US EPA Health and Environmental Effects Profile for 1-Amino-2-naphthol and 1- amino-2-naphtol hydrochloride

Lin GHY, Mutagenesis, 3, 311, 10.1093/mutage/3.4.311

Shahin MM, Mutat Res, 68, 327, 10.1016/0165-1218(79)90165-4

Shahin MM, Internatl J Cosmet Sci, 7, 277, 10.1111/j.1467-2494.1985.tb00422.x

Shahin M, Mutat Res, 22, 165

Chung K-T, Toxicol Letters, 81, 23, 10.1016/0378-4274(95)03404-8

Watanabe T, Mutat Res., 245, 15, 10.1016/0165-7992(90)90019-G

Sontag JM, J Natl Canc Inst, 66, 591

Rollison DE, J Toxicol Environ Health. Part B, 9, 413, 10.1080/10937400600681455

Bolt HM, Crit Rev Toxicol, 37, 521, 10.1080/10408440701385671

Turesky RJ, Chem Res Toxicol, 16, 1162, 10.1021/tx030029r

Collier SW, Toxico Appl Pharmacol, 118, 73, 10.1006/taap.1993.1011

Watanabe T, Mutat Res., 245, 125

Bomhard EM, Crit Rev Toxicol, 35, 783, 10.1080/10408440500442384

Kahl T, “Aniline” in Ullmann's Encyclopedia of Industrial Chemistry

NTP, Natl Toxicol Program Tech Rep Ser., 418, 1

p-Nitroaniline: Evaluation of the carcinogenicity and genotoxicity

Osano O, Arch Contam Toxicol., 43, 42, 10.1007/s00244-002-1132-4

Yoshimi N, Mutat Res, 206, 183, 10.1016/0165-1218(88)90159-0

Danflora N, Mutat Res., 258, 207

Sellers C, Regu Toxicol Pharmacol., 16, 301, 10.1016/0273-2300(92)90010-7

Anon, Cancer of the bladder among workers in aniline factories

Richter E, Front in Biosci Elite, 7, 305

IARC, IARC Monogr Eval Carcinog Risks Hum, 77, 267

Carreon T, Occup Environ Med., 67, 348, 10.1136/oem.2009.051136

EurekAlert, Deutsche Forschungsgemeinschaft. DFG presents. The 2006 List of MAK and BAT Values List. Focus on health protection during pregnancy

IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1

Chung K-T, Mutat Res, 387, 1, 10.1016/S1383-5742(97)00019-7

Morton LO, Toxicol Pathol, 30, 559, 10.1080/01926230290105794

National Toxicology Program, Bioassay of 2-Nitro-p-phenylenediamine for possible carcinogenicity (CAS No. 5307-14-2), FDA

Commission of the European Communities, Off 1 Eu Commun., 91, 59

Natl Toxicol Program Tech Rep Ser, 339, 1

IARC, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France, 27, 103

Bioassay of2, 4-diaminoanisole sulfate for possible carcinogenicity Tech Rep Ser No. 84; DHEW Publ. No. (NIH). National Cancer Institute. Washington DC: Government Printing Office; 1978;78–1334.

IARC.Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Thyrotropic Agents. Lyon, France; 2001;79:1–780.

Matsumoto M, Arch Toxicol., 86, 791, 10.1007/s00204-012-0800-z

Gosselin EE, Smith RP, Hodge HC.Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins; 1984;11–210.

Srrift AF, Mutat Res, 321, 43

Ames BN, Proc Natl Acad Sci. U.S.A., 72, 2423, 10.1073/pnas.72.6.2423

Renault J, Eur J Med Chem., 16, 545

Deshpande SS.Enzyme Immunoassays: From Concept to Product Development. New York: Chapman & Hall; 1996;169. ISBN 978-0-412-05601-7.

1, 3-Benzenediamine from HSDB 5384 NIH

Thyssen JP, Contact Dermat., 59, 327, 10.1111/j.1600-0536.2008.01427.x

Kleniewska D, Derm Beruf Umwelt, 28, 11

ATSDR, Agency for Toxic Substances and Disease Registry. Toxicological Profile for Benzidine

US Environmental Protection Agency, Integrated Risk Information System (IRIS) on Benzidine

NTP, National Institutes of Health Technical Report Series. US Department of Health and Human Services Public Service

Elhkim MO, Reg Toxicol. Pharmacol., 47, 308, 10.1016/j.yrtph.2006.11.004

Dipalma JR, 1990, American Family Physician, 42, 1347

10.1016/S0140-6736(07)61306-3

EFSA, The EFSA J. 2008, 660, 1

10.1016/S0022-3476(06)80164-2

2009, In European Food Safety Authority. EFSA Journal, 7, 1331

Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill; 1994;604.

10.1016/j.tox.2005.11.005

Joe EK, 2007, Dermat Online J, 7, 9

Mathur N, 2012, Universal J Environ Res Technol, 2, 1

10.1016/S1046-199X(00)90030-7

Hartman CP, 1978, Mutat Res, 58, 25

10.1289/ehp.94102s6119

10.1134/S1022795406060044

Yoshida O, 1973, In Analytical and Experimental Epidemiology of Cancer” Proceedings of the Third International Symposium on the Princess Takmutsu Cancer Research Fund Japan

Usha M, 1989, Impact analysis of industries in Sanganer. P. G. Diploma Field Study Report Submitted to Indira Gandhi Center for HEEPS

10.1016/0165-7992(90)90160-L

10.1002/(SICI)1097-0274(199701)31:1<44::AID-AJIM7>3.0.CO;2-X

10.1007/s00253-006-0658-1

10.1016/j.jtice.2010.06.006

10.1016/j.jhazmat.2010.10.087

10.1016/j.ibiod.2006.08.006

10.1016/S0960-8524(96)00113-7

Bae JS, 2007, Dyes Pigment, 73, 1937

Chequer FMD, 2011, In Advances in Treating Textile Effluent, 1

10.1016/S0032-9592(00)00274-0